In the fitness world, timing often becomes just as important as the supplement itself
Research in postmenopausal women suggests that combining these therapies can achieve a greater response to weight loss in upwards of 30% more in obese patients treated with dual therapy
Radiotracer imaging studies in patients with AUD (Volkow et al., 1996), cocaine users (Volkow et al., 1993) and methamphetamine users (Volkow et al., 2001) have reported of decreased postsynaptic dopamine receptor availability, which is suggested as one of the explanations for lower dopamine function in this group of patients (Nutt et al., 2015)
One popular approach is to combine IGF-1 LR3 with growth hormone secretagogues such as CJC-1295 or Ipamorelin
(PubMed) Wen YY, Yang SJ, Zhang JX, Chen XY